Arena Pharmaceuticals, Inc. Interest Expense on Debt
Arena Pharmaceuticals, Inc. reported Interest Expense on Debt of $1.90 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-03-02.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2015-03-02
- Arena Pharmaceuticals, Inc. interest expense, debt for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- Arena Pharmaceuticals, Inc. interest expense, debt for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- Arena Pharmaceuticals, Inc. interest expense, debt for the quarter ending 2012-06-30 was $700.00K, a 41.67% decline year-over-year.
- Arena Pharmaceuticals, Inc. interest expense, debt for the quarter ending 2011-12-31 was $1.40M.
- Arena Pharmaceuticals, Inc. interest expense, debt for fiscal 2012 was $1.90M, a 71.21% decline from fiscal 2011.
- Arena Pharmaceuticals, Inc. interest expense, debt for fiscal 2011 was $6.60M, a 52.86% decline from fiscal 2010.
- Arena Pharmaceuticals, Inc. interest expense, debt for fiscal 2010 was $14.00M.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month | Interest Expense, Debt 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $0.00 derived: sum of 2 quarters · filed 2015-03-02 | $700.00K derived: sum of 3 quarters · filed 2015-03-02 | $1.90M 10-K · filed 2015-03-02 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-09 | $700.00K derived: sum of 2 quarters · filed 2012-11-09 | $1.90M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $700.00K 10-Q · filed 2012-08-09 | $1.90M 10-Q · filed 2012-08-09 | ||
| 2011-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $2.70M derived: sum of 2 quarters · filed 2014-03-03 | $3.90M derived: sum of 3 quarters · filed 2014-03-03 | $6.60M 10-K · filed 2014-03-03 |
| 2011-09-30 | $1.30M 10-Q · filed 2012-11-09 | $2.50M derived: sum of 2 quarters · filed 2012-11-09 | $5.20M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $1.20M 10-Q · filed 2012-08-09 | $3.90M 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | $14.00M 10-K · filed 2013-03-01 |